Tumor Necrosis Factors and Receptors (TNFs)
209 products
209 products
In the field of immunology and oncology, tumor necrosis factor (TNF) plays a critical role. This important cytokine regulates inflammation, cell death, and immune responses throughout the body. Due to its powerful effects, TNF has become a major focus for therapeutic research targeting autoimmune diseases, cancer, and chronic inflammatory disorders.
At Beta LifeScience, we offer a curated collection of recombinant tumor necrosis factor proteins and receptors, designed to support your research in developing therapies and diagnostics. Whether you are studying disease pathways or creating next-generation biologics, our TNF proteins deliver the reliability and quality you need.
Tumor necrosis factor (TNF) is a type of cytokine — a small signaling protein — that cells use to communicate during immune responses. TNF plays a pivotal role in inflammation, helping the body respond to infection or injury. It can induce fever, apoptosis (programmed cell death), and inhibit tumor growth under certain conditions.
Discovered for its ability to cause the death of tumor cells, TNF soon revealed broader importance. High levels of TNF are now associated with many chronic diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. For this reason, tumor necrosis factor inhibitors have become a cornerstone of modern treatment strategies.
The most well-studied form of TNF is tumor necrosis factor alpha (TNF-α). Produced mainly by macrophages, TNF-α drives the body's response to infection by promoting inflammation and recruiting immune cells to the site of injury.
However, when TNF-α production becomes excessive or uncontrolled, it contributes to chronic inflammation and tissue damage. This is why tumor necrosis factor alpha is heavily targeted by modern therapeutic drugs seeking to control autoimmune diseases.
Beta LifeScience provides high-purity recombinant tumor necrosis factor alpha proteins to facilitate your research in immunology, inflammation, and beyond.
When properly regulated, TNF is essential for immune protection. But overactive TNF signaling is linked to a wide range of diseases:
Understanding how TNF operates — and how to modulate its effects — is crucial for advancing therapies across multiple fields of medicine.
Because of its powerful role in driving inflammation, blocking TNF has become a major therapeutic strategy. Tumor necrosis factor inhibitors are biologic drugs designed to neutralize TNF’s activity, reducing inflammation and preventing tissue damage.
Some common TNF inhibitors include:
Similarly, a tumor necrosis factor blocker refers to any agent that interrupts TNF’s interaction with its receptors, reducing its ability to promote inflammation.
Research into new tumor necrosis factor blockers continues today, with goals of improving efficacy, reducing side effects, and expanding use across more diseases.
At Beta LifeScience, we are committed to empowering scientific discovery. Our collection of recombinant tumor necrosis factor proteins and receptors is manufactured to ensure:
When you partner with Beta LifeScience, you gain access to research-grade materials trusted by scientists worldwide.
Our TNF products are ideal for:
The biological activity of tumor necrosis factor makes it a central target in many areas of research. Its role in regulating immune response and inflammation allows scientists to explore and influence critical disease processes. Recombinant TNF proteins serve as powerful tools in both basic and applied studies, with applications spanning multiple therapeutic domains.
One of the most prominent uses of TNF proteins lies in the development of therapies for autoimmune disorders. Diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease are driven by an overactive immune response, often fueled by elevated TNF levels. By using recombinant TNF in research, scientists can better understand the pathways involved and screen potential tumor necrosis factor inhibitors to control this immune overreaction.
TNF's relationship with cancer is complex and multifaceted. While it was initially identified for its ability to cause tumor cell death, TNF can also promote tumor survival under certain inflammatory conditions. Researchers use TNF proteins to investigate this dual role — studying how it may be harnessed for anti-tumor strategies or how blocking it may improve patient outcomes in cancer therapy.
As a potent cytokine, tumor necrosis factor alpha plays a critical role in stimulating immune responses. This property is particularly valuable in the development of vaccines and immunotherapies. Researchers utilize TNF proteins to understand how immune cells are activated and how inflammatory signals can be modulated to improve vaccine efficacy.
Emerging studies have shown that TNF is involved in neuroinflammatory processes linked to conditions like multiple sclerosis, Alzheimer’s disease, and even depression. Recombinant TNF proteins allow scientists to replicate and observe these responses in controlled models, helping uncover potential intervention strategies to protect the brain from chronic inflammation and degeneration.
At Beta LifeScience, we support all these avenues of research by providing high-quality, biologically active TNF proteins. With our tools, scientists can confidently explore the molecular mechanisms behind disease and develop innovative therapies that improve human health.
In the pursuit of new medical breakthroughs, access to reliable and biologically relevant proteins is crucial. Recombinant tumor necrosis factor proteins provide researchers with the precise tools they need to decode TNF’s role in health and disease and to move from early discovery to real-world therapeutic development.
These proteins are essential for exploring how TNF interacts with receptors, immune cells, and various signaling molecules within the body. By using recombinant TNF in laboratory settings, scientists can recreate physiological conditions and observe the outcomes of TNF modulation, whether activating it to promote immune defense or blocking it to reduce chronic inflammation.
One of the most valuable applications is in drug screening. Recombinant TNF is widely used to test the effectiveness of both established and experimental tumor necrosis factor blockers. This allows pharmaceutical researchers to evaluate binding affinities, biological activity, and therapeutic potential early in the development process.
Additionally, recombinant TNF proteins help identify and refine tumor necrosis factor inhibitors that are selective, safe, and potent. This precision is vital when designing biologics that must interact with the immune system without causing widespread immune suppression.
At Beta LifeScience, we take pride in offering recombinant TNF proteins that meet strict quality standards. Each product is validated for purity, correct folding, and consistent activity, ensuring you can trust your results from one experiment to the next. Whether you're engaged in fundamental research or advancing a preclinical therapeutic, our TNF collection is built to support your mission every step of the way.
Tumor necrosis factor (TNF) is a cytokine involved in systemic inflammation. It helps regulate immune cells, promotes fever, and can induce apoptosis (cell death). While critical for fighting infections, excessive TNF activity contributes to chronic diseases like arthritis and psoriasis.
Tumor necrosis factor alpha (TNF-α) is the most studied form of TNF. Produced mainly by immune cells like macrophages, TNF-α triggers inflammation and recruits other immune cells to areas of infection or injury. Dysregulated TNF-α activity is associated with many autoimmune diseases.
Tumor necrosis factor inhibitors are drugs designed to block the activity of TNF, reducing inflammation in autoimmune diseases like rheumatoid arthritis, Crohn’s disease, and psoriasis. They include monoclonal antibodies and soluble TNF receptors that neutralize TNF in the body.
Tumor necrosis factor blockers prevent TNF from binding to its receptors on cell surfaces. By interrupting this signaling pathway, they help reduce inflammation, decrease symptoms, and prevent damage to tissues in autoimmune and inflammatory diseases.
TNF plays a complex role in cancer. In some cases, it helps destroy tumors by promoting immune responses. In others, it can aid tumor growth by fostering inflammation. Understanding TNF’s dual nature is critical for designing effective cancer therapies.